Resveratrol Enhances the Antitumor Effects of Temozolomide in Glioblastoma via ROS‐dependent AMPK‐TSC‐mTOR Signaling Pathway

Yuan Yuan(Jiangsu Cancer Hospital), Gang Hu(University of Kansas), Xiu‐Lan Sun(Nanjing University of Chinese Medicine), Xue Xue(Nanjing Medical University), Ruo‐Bing Guo(Nanjing Medical University)
CNS Neuroscience & Therapeutics
April 25, 2012
Cited by 129


Related Papers